Demand for drug delivery products in the US will rise 6.1 percent yearly to $251 billion in 2019. Parenteral products will grow the fastest, driven by monoclonal antibodies and polymer-encapsulated medicines. Hormones and central nervous system agents will lead gains by application. Pen injectors and retractable prefillable syringes will pace devices.This study analyzes the $187 billion US drug delivery system industry. It presents historical demand data (2004, 2009 and 2014) and forecasts (2019 and 2024) by product (e.g., oral, parenteral, inhalation, transdermal, implantable) and application (e.g., central nervous system, hormones, respiratory, anti-infective, cardiovascular, gastrointestinal, nutritional).The study also considers market environment factors, details industry structure, evaluates company market share, and profiles 30 industry players, including Gilead Sciences, Roche, and Johnson & Johnson.
Freedonia Market Research—Reports provide industry insights targeting market size, product and market segmentation, product and market forecasts, industry composition, market leaders and business trends.
Any questions about the report you're considering?
Our Customer Service Team can help! Or visit our FAQs.
Search all our
from one place.